Lustgarten Foundation Research Funding Opportunities
Concept Due Date: May 24, 2013
Full Applications Due: August 9, 2013
Funding to begin January 2014
The Lustgarten Foundation (LF) is the nation’s largest private funder of pancreatic cancer research. Our mission is to advance scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer. Thanks to the support of Cablevision, 100% of all our donations go directly to research, which has enabled us to commit $65 Million to outstanding research projects to date.
For the 2013 Grant application cycle, The Foundation’s Scientific Review Board has identified a number of research areas for which proposals are now being solicited (below).
Research Topics
Clinical/Translational RFA's
Early Detection and Risk Assessment in Pancreas Cancer
New Drug Delivery Approaches in Pancreas Cancer
Novel Imaging Technologies in Pancreas Cancer
Novel Therapeutic Agents in Pancreas Cancer
Correlative Studies Awards Program
Preclinical RFA's
Novel Agents for Pancreas Cancer
Clinical and Molecular Markers of Metastic Burden
Basic RFA's
Immune Surveillance and Modulation
Early Stage Target Validation for Pancreas Cancer
Impact of Chromatin Alteration in Pancreas Cancer
New Models of PDAC